Arthritis Research & Therapy

official impact factor 4.36

This article is part of the supplement: Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review

Highly Access

Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review

Andrea Rubbert-Roth* and Axel Finckh

Arthritis Research & Therapy 2009, 11(Suppl 1):S1 doi:10.1186/ar2666

Accesses  

  • Last 30 days: 251 accesses
  • Last 365 days: 2122 accesses
  • All time: 9982 accesses